scholarly journals Familial visceral myopathy

2020 ◽  
Author(s):  
Keyword(s):  

2018 ◽  
Vol 27 (1) ◽  
pp. 77-83 ◽  
Author(s):  
Rebecca R. J. Collins ◽  
Bradley Barth ◽  
Stephen Megison ◽  
Cory M. Pfeifer ◽  
Luke M. Rice ◽  
...  

Primary visceral myopathy caused by a pathogenic mutation in the gene encoding the enteric smooth muscle actin gamma 2 ( ACTG2) affects gastrointestinal and genitourinary tracts and often presents as chronic intestinal pseudoobstruction. We present a case of pediatric onset chronic intestinal pseudoobstruction associated with a novel missense ACTG2 mutation c.439G>T/p.G147C. In addition to the known disease manifestations of feeding intolerance and intestinal malrotation, our patient had a late-onset hypertrophic pyloric stenosis and a late-onset choledochal cyst, the former of which has not previously been described in patients with ACTG2-associated visceral myopathy.



Author(s):  
Sohaib Khalid Hashmi ◽  
Rachel Helen Ceron ◽  
Robert O Heuckeroth

Visceral smooth muscle is a crucial component of the walls of hollow organs like the gut, bladder, and uterus. This specialized smooth muscle has unique properties that distinguish it from other muscle types and that facilitate robust dilation and contraction. Visceral myopathies are diseases where severe visceral smooth muscle dysfunction prevents efficient movement of air and nutrients though the bowel, impairs bladder emptying, and affects normal uterine contraction and relaxation, particularly during pregnancy. Disease severity exists along a spectrum. The most debilitating defects cause highly dysfunctional bowel, reduced intrauterine colon growth (microcolon), and bladder emptying defects requiring catheterization, a condition called Megacystis Microcolon Intestinal Hypoperistalsis Syndrome (MMIHS). People with MMIHS often die early in childhood. When the bowel is the main organ affected and microcolon is absent, the condition is known as myopathic chronic intestinal pseudo-obstruction (CIPO). Visceral myopathies like MMIHS and myopathic CIPO are most commonly caused by mutations in contractile apparatus cytoskeletal proteins. Here, we review visceral myopathy-causing mutations and normal functions of these disease-associated proteins. We propose molecular, cellular, and tissue-level models that may explain clinical and histopathological features of visceral myopathy and hope these observations prompt new mechanistic studies.



2015 ◽  
Vol 110 ◽  
pp. S168
Author(s):  
Celeste P. Pizza ◽  
Kasra Adham ◽  
Douglas J. Grider ◽  
Alan Brijbassie


1978 ◽  
Vol 74 (5) ◽  
pp. 1003 ◽  
Author(s):  
S. Anuras ◽  
D.L. Faulk ◽  
S. Shirazi ◽  
R.W. Summers ◽  
J. Christensen


Gut ◽  
1991 ◽  
Vol 32 (3) ◽  
pp. 334-337 ◽  
Author(s):  
P I Mansell ◽  
R B Tattersall ◽  
M Balsitis ◽  
J Lowe ◽  
R C Spiller


Gut ◽  
1993 ◽  
Vol 34 (7) ◽  
pp. 999-1001 ◽  
Author(s):  
J E Martin ◽  
M Benson ◽  
M Swash ◽  
V Salih ◽  
A Gray
Keyword(s):  


2013 ◽  
Vol 45 (10) ◽  
pp. 866
Author(s):  
Robert J. Huang ◽  
Chohee Yun ◽  
Linda Nguyen
Keyword(s):  


1992 ◽  
Vol 37 (3) ◽  
pp. 464-469 ◽  
Author(s):  
S. C. Jones ◽  
M. F. Dixon ◽  
D. J. Lintott ◽  
A. T. R. Axon
Keyword(s):  


2000 ◽  
Vol 89 (6) ◽  
pp. 733-736 ◽  
Author(s):  
A Kansu ◽  
A Ensari ◽  
AG Kalayci ◽  
N Girgin


Sign in / Sign up

Export Citation Format

Share Document